378 related articles for article (PubMed ID: 8561506)
21. Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11).
Klekotka PA; Halpert JR
Drug Metab Dispos; 1995 Dec; 23(12):1434-5. PubMed ID: 8689957
[No Abstract] [Full Text] [Related]
22. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
23. Specificity of self-assembly of cytochrome P450.
Myasoedova KN
Biochemistry (Mosc); 1998 Dec; 63(12):1395-9. PubMed ID: 9916156
[TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of cytochrome P450 isozymes from beta-naphthoflavone-induced adult hen liver.
Gupta RP; Lapadula DM; Abou-Donia MB
Arch Biochem Biophys; 1990 Oct; 282(1):170-82. PubMed ID: 2171427
[TBL] [Abstract][Full Text] [Related]
25. Mapping of interaction between cytochrome P450 2B4 and cytochrome b5: the first evidence of two mutual orientations.
Sulc M; Jecmen T; Snajdrova R; Novak P; Martinek V; Hodek P; Stiborova M; Hudecek J
Neuro Endocrinol Lett; 2012; 33 Suppl 3():41-7. PubMed ID: 23353842
[TBL] [Abstract][Full Text] [Related]
26. Insights into the role of substrates on the interaction between cytochrome b5 and cytochrome P450 2B4 by NMR.
Zhang M; Le Clair SV; Huang R; Ahuja S; Im SC; Waskell L; Ramamoorthy A
Sci Rep; 2015 Feb; 5():8392. PubMed ID: 25687717
[TBL] [Abstract][Full Text] [Related]
27. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170
[No Abstract] [Full Text] [Related]
28. Beta-naphthoflavone induction of a cytochrome P-450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital-induced arachidonate epoxygenase.
Nakai K; Ward AM; Gannon M; Rifkind AB
J Biol Chem; 1992 Sep; 267(27):19503-12. PubMed ID: 1527070
[TBL] [Abstract][Full Text] [Related]
29. Activation of alkylhydrazines to free radical intermediates by ethanol-inducible cytochrome P-4502E1 (CYP2E1).
Albano E; Comoglio A; Clot P; Iannone A; Tomasi A; Ingelman-Sundberg M
Biochim Biophys Acta; 1995 Apr; 1243(3):414-20. PubMed ID: 7727516
[TBL] [Abstract][Full Text] [Related]
30. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides.
Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D
Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
32. [Isolation and properties of cytochrome P-450 from rabbit liver microsomes].
Karuzina II; Bachmanova GI; Mengazetdinov DE; Miasoedova KN; Zhikhareva VO
Biokhimiia; 1979 Jun; 44(6):1049-57. PubMed ID: 465602
[TBL] [Abstract][Full Text] [Related]
33. Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities.
Hanna IH; Teiber JF; Kokones KL; Hollenberg PF
Arch Biochem Biophys; 1998 Feb; 350(2):324-32. PubMed ID: 9473308
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of cytochrome P4501A1 amino acid residues interacting with a radiolabeled photoaffinity diazido-benzphetamine analogue.
Cvrk T; Hodek P; Strobel HW
Arch Biochem Biophys; 1996 Jun; 330(1):142-52. PubMed ID: 8651689
[TBL] [Abstract][Full Text] [Related]
35. Effect of different solubilizing agents on the aggregation state and catalytic activity of two purified rabbit cytochrome P450 isozymes, CYP1A2 (LM4) and CYP2B4 (LM2).
Viner RI; Novikov KN; Ritov VB; Kagan VE; Alterman MA
Biochem Biophys Res Commun; 1995 Dec; 217(3):886-91. PubMed ID: 8554612
[TBL] [Abstract][Full Text] [Related]
36. Differential interaction of erythromycin with cytochromes P450 3A1/2 in the endoplasmic reticulum: a CO flash photolysis study.
Koley AP; Dai R; Robinson RC; Markowitz A; Friedman FK
Biochemistry; 1997 Mar; 36(11):3237-41. PubMed ID: 9116001
[TBL] [Abstract][Full Text] [Related]
37. N-aralkyl derivatives of 1-aminobenzotriazole as potent isozyme-selective mechanism-based inhibitors of rabbit pulmonary cytochrome P450 in vivo.
Mathews JM; Bend JR
J Pharmacol Exp Ther; 1993 Apr; 265(1):281-5. PubMed ID: 8474011
[TBL] [Abstract][Full Text] [Related]
38. Crosslinking of cytochrome c and cytochrome b5 with a water-soluble carbodiimide. Reaction conditions, product analysis and critique of the technique.
Mauk MR; Mauk AG
Eur J Biochem; 1989 Dec; 186(3):473-86. PubMed ID: 2558010
[TBL] [Abstract][Full Text] [Related]
39. Modulation of cytochrome P450 enzyme system by selected flavonoids.
Hodek P; Tepla M; Krizkova J; Sulc M; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():67-71. PubMed ID: 20027147
[TBL] [Abstract][Full Text] [Related]
40. Interaction between cytochrome P450 2B1 and cytochrome bs: inhibition by synthetic peptides indicates a role for P450 residues Lys-122 and Arg-125.
Omata Y; Sakamoto H; Robinson RC; Pincus MR; Friedman FK
Biochem Biophys Res Commun; 1994 Jun; 201(3):1090-5. PubMed ID: 8024550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
